Identification of Differentially Expressed Genes Particularly Associated with Immunity in Uremia Patients by Bioinformatic Analysis

被引:1
作者
Li, Guixia [1 ]
Wang, Shijun [2 ]
Huo, Jing [1 ]
机构
[1] Changzhi Med Coll, Dept Basic Med, Changzhi 046000, Peoples R China
[2] Changzhi Univ, Dept Chem, Changzhi 046000, Peoples R China
关键词
KIDNEY; DISEASE; GENDER; SEX; OUTCOMES; CELL;
D O I
10.1155/2022/5437560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uremia is a common syndrome that happens to nearly all end-stage kidney diseases, which profound have changes in human gene expressions, but the related pathways are poorly understood. Gene Ontology categories and Kyoto Encyclopedia of Genes and Genomes pathways enriched in the differentially expressed genes (DEGs) were analyzed by using clusterProfiler, org.Hs.eg.db, and Pathview, and protein-protein interaction (PPI) network was built by Cytoscape. We identified 3432 DEGs (including 3368 down- and 64 up-regulated genes), of which there were 52 different molecular functions, and 178 genes were identified as immune genes controlled by the four transcription factors (POU domain class 6 transcription factor 1 (POU6F1), interferon regulator factor 7 [IRF7], forkhead box D3 (FOXD3), and interferon-stimulated response element [ISRE]). In the gender research, no significant difference was observed. The top 15 proteins of 178 immune-related genes were identified with the highest degree in PPI network. The DEG analysis of uremia patients was expected to provide fundamental information to relieve pain and add years to their life.
引用
收藏
页数:11
相关论文
共 34 条
  • [1] Immune cell dysfunction and inflammation in end-stage renal disease
    Betjes, Michiel G. H.
    [J]. NATURE REVIEWS NEPHROLOGY, 2013, 9 (05) : 255 - 265
  • [2] Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
    Carrero, Juan Jesus
    Hecking, Manfred
    Chesnaye, Nicholas C.
    Jager, Kitty J.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (03) : 151 - 164
  • [3] Sepsis in end-stage renal disease patients: are they at an increased risk of mortality?
    Chebl, Ralphe Bou
    Tamim, Hani
    Abou Dagher, Gilbert
    Sadat, Musharaf
    Ghamdi, Ghassan
    Itani, Abdulrahman
    Saeedi, Alawi
    Arabi, Yaseen M.
    [J]. ANNALS OF MEDICINE, 2021, 53 (01) : 1737 - 1743
  • [4] Dysregulated Oxygen Metabolism of the Kidney by Uremic Toxins: Review
    Chiang, Chih-Kang
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    [J]. JOURNAL OF RENAL NUTRITION, 2012, 22 (01) : 77 - 80
  • [5] The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects
    Ciceri, Paola
    Artioli, Luisa
    Magagnoli, Lorenza
    Barassi, Alessandra
    Alvarez, Jean-Claude
    Massy, Ziad A. A.
    Galassi, Andrea
    Cozzolino, Mario
    [J]. BLOOD PURIFICATION, 2023, 52 (01) : 41 - 53
  • [6] Immune Dysfunction in Uremia 2020
    Cohen, Gerald
    [J]. TOXINS, 2020, 12 (07)
  • [7] Potential contribution of the immune system to the emergence of renal diseases
    Ghassabi, Ali
    Motavalli, Roza
    Iranzad, Rahim
    Pourakbari, Ramin
    Etemadi, Jalal
    Dolati, Sanam
    Yousefi, Mehdi
    [J]. IMMUNOLOGY LETTERS, 2022, 248 : 1 - 6
  • [8] Molecular aspects of T- and B-cell function in uremia
    Girndt, M
    Sester, M
    Sester, U
    Kaul, H
    Köhler, H
    [J]. KIDNEY INTERNATIONAL, 2001, 59 : S206 - S211
  • [9] Impaired cellular immune function in patients with end-stage renal failure
    Girndt, M
    Sester, U
    Sester, M
    Kaul, H
    Köhler, H
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) : 2807 - 2810
  • [10] Monocytes in Uremia
    Girndt, Matthias
    Trojanowicz, Bogusz
    Ulrich, Christof
    [J]. TOXINS, 2020, 12 (05)